Works by Loi, Sherene

Results: 99
    1

    Advancing equitable access to innovation in breast cancer.

    Published in:
    NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00768-1
    By:
    • O'Reilly, Seamus;
    • Luis, Ines Vaz;
    • Adam, Virginie;
    • Razis, Evangelia D.;
    • Urruticoechea, Ander;
    • Arahmani, Amal;
    • Carrasco, Eva;
    • Chua, Boon H.;
    • Bliss, Judith;
    • Straehle, Carolyn;
    • Goulioti, Theodora;
    • Lindholm, Barbro;
    • Werustsky, Gustavo;
    • Brain, Etienne;
    • Bedard, Philippe L.;
    • Curigliano, Giuseppe;
    • Loi, Sherene;
    • Saji, Shigehira;
    • Cameron, David
    Publication type:
    Article
    2
    3

    Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up

    Published in:
    Oncologist, 2021, v. 26, n. 5, p. e749, doi. 10.1002/onco.13684
    By:
    • Finn, Richard S.;
    • Rugo, Hope S.;
    • Gelmon, Karen A.;
    • Cristofanilli, Massimo;
    • Colleoni, Marco;
    • Loi, Sherene;
    • Schnell, Patrick;
    • Lu, Dongrui R.;
    • Theall, Kathy Puyana;
    • Mori, Ave;
    • Gauthier, Eric;
    • Bananis, Eustratios;
    • Turner, Nicholas C.;
    • Diéras, Véronique
    Publication type:
    Article
    4

    Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.

    Published in:
    Oncologist, 2017, v. 22, n. 9, p. 1028, doi. 10.1634/theoncologist.2017-0072
    By:
    • Loibl, Sibylle;
    • Turner, Nicholas C.;
    • Ro, Jungsil;
    • Cristofanilli, Massimo;
    • Iwata, Hiroji;
    • Im, Seock‐Ah;
    • Masuda, Norikazu;
    • Loi, Sherene;
    • André, Fabrice;
    • Harbeck, Nadia;
    • Verma, Sunil;
    • Folkerd, Elizabeth;
    • Puyana Theall, Kathy;
    • Hoffman, Justin;
    • Zhang, Ke;
    • Bartlett, Cynthia Huang;
    • Dowsett, Mitchell
    Publication type:
    Article
    5

    Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).

    Published in:
    Oncologist, 2016, v. 21, n. 10, p. 1165, doi. 10.1634/theoncologist.2016-0097
    By:
    • Verma, Sunil;
    • Bartlett, Cynthia Huang;
    • Schnell, Patrick;
    • DeMichele, Angela M.;
    • Loi, Sherene;
    • Ro, Jungsil;
    • Colleoni, Marco;
    • Iwata, Hiroji;
    • Harbeck, Nadia;
    • Cristofanilli, Massimo;
    • Zhang, Ke;
    • Thiele, Alexandra;
    • Turner, Nicholas C.;
    • Rugo, Hope S.
    Publication type:
    Article
    6
    7

    Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-54621-3
    By:
    • Rediti, Mattia;
    • Venet, David;
    • Joaquin Garcia, Andrea;
    • Maetens, Marion;
    • Vincent, Delphine;
    • Majjaj, Samira;
    • El-Abed, Sarra;
    • Di Cosimo, Serena;
    • Ueno, Takayuki;
    • Izquierdo, Miguel;
    • Piccart, Martine;
    • Pusztai, Lajos;
    • Loi, Sherene;
    • Salgado, Roberto;
    • Viale, Giuseppe;
    • Rothé, Françoise;
    • Sotiriou, Christos
    Publication type:
    Article
    8
    9
    10
    11

    INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23241-6
    By:
    • Rodgers, Samuel J.;
    • Ooms, Lisa M.;
    • Oorschot, Viola M. J.;
    • Schittenhelm, Ralf B.;
    • Nguyen, Elizabeth V.;
    • Hamila, Sabryn A.;
    • Rynkiewicz, Natalie;
    • Gurung, Rajendra;
    • Eramo, Matthew J.;
    • Sriratana, Absorn;
    • Fedele, Clare G.;
    • Caramia, Franco;
    • Loi, Sherene;
    • Kerr, Genevieve;
    • Abud, Helen E.;
    • Ramm, Georg;
    • Papa, Antonella;
    • Ellisdon, Andrew M.;
    • Daly, Roger J.;
    • McLean, Catriona A.
    Publication type:
    Article
    12
    13

    CD4+ follicular helper T cell infiltration predicts breast cancer survival.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 7, p. 2873, doi. 10.1172/JCI67428
    By:
    • Chunyan Gu-Trantien;
    • Loi, Sherene;
    • Garaud, Soizic;
    • Equeter, Carole;
    • Libin, Myriam;
    • de Wind, Alexandre;
    • Ravoet, Marie;
    • Le Buanec, Hélène;
    • Sibille, Catherine;
    • Manfouo-Foutsop, Germain;
    • Veys, Isabelle;
    • Haibe-Kains, Benjamin;
    • Singhal, Sandeep K.;
    • Michiels, Stefan;
    • Rothé, Françoise;
    • Salgado, Roberto;
    • Duvillier, Hugues;
    • Ignatiadis, Michail;
    • Desmedt, Christine;
    • Bron, Dominique
    Publication type:
    Article
    14

    Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

    Published in:
    2017
    By:
    • Savas, Peter;
    • Teo, Zhi Ling;
    • Lefevre, Christophe;
    • Flensburg, Christoffer;
    • Caramia, Franco;
    • Alsop, Kathryn;
    • Mansour, Mariam;
    • Francis, Prudence A.;
    • Thorne, Heather A.;
    • Silva, Maria Joao;
    • Kanu, Nnennaya;
    • Dietzen, Michelle;
    • Rowan, Andrew;
    • Kschischo, Maik;
    • Fox, Stephen;
    • Bowtell, David D.;
    • Dawson, Sarah-Jane;
    • Speed, Terence P.;
    • Swanton, Charles;
    • Loi, Sherene
    Publication type:
    corrected article
    15

    The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

    Published in:
    2016
    By:
    • Savas, Peter;
    • Teo, Zhi Ling;
    • Lefevre, Christophe;
    • Flensburg, Christoffer;
    • Caramia, Franco;
    • Alsop, Kathryn;
    • Mansour, Mariam;
    • Francis, Prudence A.;
    • Thorne, Heather A.;
    • Silva, Maria Joao;
    • Kanu, Nnennaya;
    • Dietzen, Michelle;
    • Rowan, Andrew;
    • Kschischo, Maik;
    • Fox, Stephen;
    • Bowtell, David D.;
    • Dawson, Sarah-Jane;
    • Speed, Terence P.;
    • Swanton, Charles;
    • Loi, Sherene
    Publication type:
    journal article
    16
    17
    18
    19

    Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00297-1
    By:
    • Zhu, Zhou;
    • Turner, Nicholas C.;
    • Loi, Sherene;
    • André, Fabrice;
    • Martin, Miguel;
    • Diéras, Véronique;
    • Gelmon, Karen A.;
    • Harbeck, Nadia;
    • Zhang, Cathy;
    • Cao, Joan Q.;
    • Yan, Zhengming;
    • Lu, Dongrui R.;
    • Wei, Ping;
    • VanArsdale, Todd L.;
    • Rejto, Paul A.;
    • Huang, Xin;
    • Rugo, Hope S.;
    • Loibl, Sibylle;
    • Cristofanilli, Massimo;
    • Finn, Richard S.
    Publication type:
    Article
    20

    Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00568-5
    By:
    • Teo, Zhi Ling;
    • O'Connor, Mark J.;
    • Versaci, Stephanie;
    • Clarke, Kylie A.;
    • Brown, Emmaline R.;
    • Percy, Luke W.;
    • Kuykhoven, Keilly;
    • Mintoff, Christopher P.;
    • Savas, Peter;
    • Virassamy, Balaji;
    • Luen, Stephen J.;
    • Byrne, Ann;
    • Sant, Sneha;
    • Lindeman, Geoffrey J.;
    • Darcy, Phillip K.;
    • Loi, Sherene
    Publication type:
    Article
    21

    Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-021-00362-1
    By:
    • Loi, Sherene;
    • Salgado, Roberto;
    • Adams, Sylvia;
    • Pruneri, Giancarlo;
    • Francis, Prudence A.;
    • Lacroix-Triki, Magali;
    • Joensuu, Heikki;
    • Dieci, Maria Vittoria;
    • Badve, Sunil;
    • Demaria, Sandra;
    • Gray, Robert;
    • Munzone, Elisabetta;
    • Drubay, Damien;
    • Lemonnier, Jerome;
    • Sotiriou, Christos;
    • Kellokumpu-Lehtinen, Pirkko Liisa;
    • Vingiani, Andrea;
    • Gray, Kathryn;
    • André, Fabrice;
    • Denkert, Carsten
    Publication type:
    Article
    22

    Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 5, p. 717, doi. 10.1093/jnci/djad240
    By:
    • Cescon, David W;
    • Schmid, Peter;
    • Rugo, Hope S;
    • Im, Seock-Ah;
    • Yusof, Mastura Md.;
    • Gallardo, Carlos;
    • Lipatov, Oleg;
    • Barrios, Carlos H;
    • Perez-Garcia, Jose;
    • Iwata, Hiroji;
    • Masuda, Norikazu;
    • Otero, Marco Torregroza;
    • Gokmen, Erhan;
    • Loi, Sherene;
    • Haiderali, Amin;
    • Zhou, Xuan;
    • Guo, Zifang;
    • Nguyen, Allison Martin;
    • Cortes, Javier
    Publication type:
    Article
    23

    Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 7, p. 805, doi. 10.1093/jnci/djad072
    By:
    • Li, Ran;
    • Sant, Sneha;
    • Brown, Emmaline;
    • Caramia, Franco;
    • Nikolic, Bronte;
    • Clarke, Kylie;
    • Byrne, Ann;
    • Gonzalez, Luis E Lara;
    • Savas, Peter;
    • Luen, Stephen J;
    • Teo, Zhi Ling;
    • Virassamy, Balaji;
    • Neeson, Paul J;
    • Darcy, Phillip K;
    • Loi, Sherene
    Publication type:
    Article
    24

    Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 12, p. 1720, doi. 10.1093/jnci/djac126
    By:
    • Ligorio, Francesca;
    • Cosimo, Serena Di;
    • Verderio, Paolo;
    • Ciniselli, Chiara Maura;
    • Pizzamiglio, Sara;
    • Castagnoli, Lorenzo;
    • Dugo, Matteo;
    • Galbardi, Barbara;
    • Salgado, Roberto;
    • Loi, Sherene;
    • Michiels, Stefan;
    • Triulzi, Tiziana;
    • Tagliabue, Elda;
    • El-Abed, Sarra;
    • Izquierdo, Miguel;
    • Azambuja, Evandro de;
    • Nuciforo, Paolo;
    • Huober, Jens;
    • Moscetti, Luca;
    • Janni, Wolfgang
    Publication type:
    Article
    25

    CD73: A potential biomarker for anti-PD-1 therapy.

    Published in:
    OncoImmunology, 2015, v. 4, n. 11, p. 1046675-1, doi. 10.1080/2162402X.2015.1046675
    By:
    • Beavis, Paul A.;
    • Slaney, Clare Y.;
    • Milenkovski, Nicole;
    • Henderson, Melissa A.;
    • Loi, Sherene;
    • Stagg, John;
    • Kershaw, Michael H.;
    • Darcy, Phillip K.
    Publication type:
    Article
    26
    27

    Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
    By:
    • Harding, James J.;
    • Piha-Paul, Sarina A.;
    • Shah, Ronak H.;
    • Murphy, Jessica J.;
    • Cleary, James M.;
    • Shapiro, Geoffrey I.;
    • Quinn, David I.;
    • Braña, Irene;
    • Moreno, Victor;
    • Borad, Mitesh;
    • Loi, Sherene;
    • Spanggaard, Iben;
    • Park, Haeseong;
    • Ford, James M.;
    • Arnedos, Mónica;
    • Stemmer, Salomon M.;
    • de la Fouchardiere, Christelle;
    • Fountzilas, Christos;
    • Zhang, Jie;
    • DiPrimeo, Daniel
    Publication type:
    Article
    28

    Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
    By:
    • Harding, James J.;
    • Piha-Paul, Sarina A.;
    • Shah, Ronak H.;
    • Murphy, Jessica J.;
    • Cleary, James M.;
    • Shapiro, Geoffrey I.;
    • Quinn, David I.;
    • Braña, Irene;
    • Moreno, Victor;
    • Borad, Mitesh;
    • Loi, Sherene;
    • Spanggaard, Iben;
    • Park, Haeseong;
    • Ford, James M.;
    • Arnedos, Mónica;
    • Stemmer, Salomon M.;
    • de la Fouchardiere, Christelle;
    • Fountzilas, Christos;
    • Zhang, Jie;
    • DiPrimeo, Daniel
    Publication type:
    Article
    29

    Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 393, p. 1, doi. 10.1126/scitranslmed.aal4922
    By:
    • Nolan, Emma;
    • Savas, Peter;
    • Policheni, Antonia N.;
    • Darcy, Phillip K.;
    • Vaillant, François;
    • Mintoff, Christopher P.;
    • Dushyanthen, Sathana;
    • Mansour, Mariam;
    • Pang, Jia-Min B.;
    • Fox, Stephen B.;
    • Perou, Charles M.;
    • Visvader, Jane E.;
    • Gray, Daniel H. D.;
    • Loi, Sherene;
    • Lindeman, Geoffrey J.
    Publication type:
    Article
    30
    31

    Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and India

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 560, doi. 10.1111/ajco.13653
    By:
    • Loi, Sherene;
    • Karapetis, Christos S.;
    • McCarthy, Nicole;
    • Oakman, Catherine;
    • Redfern, Andrew;
    • White, Michelle;
    • Khasraw, Mustafa;
    • Doval, Dinesh Chandra;
    • Gore, Vinod;
    • Alam, Mahmood;
    • Binko, Justin;
    • Lu, Dongrui Ray;
    • Kim, Sindy;
    • Boyle, Frances
    Publication type:
    Article
    32
    33
    34
    35
    36

    Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42635-2
    By:
    • Rediti, Mattia;
    • Fernandez-Martinez, Aranzazu;
    • Venet, David;
    • Rothé, Françoise;
    • Hoadley, Katherine A.;
    • Parker, Joel S.;
    • Singh, Baljit;
    • Campbell, Jordan D.;
    • Ballman, Karla V.;
    • Hillman, David W.;
    • Winer, Eric P.;
    • El-Abed, Sarra;
    • Piccart, Martine;
    • Di Cosimo, Serena;
    • Symmans, William Fraser;
    • Krop, Ian E.;
    • Salgado, Roberto;
    • Loi, Sherene;
    • Pusztai, Lajos;
    • Perou, Charles M.
    Publication type:
    Article
    37
    38
    39

    Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00728-9
    By:
    • Dushyanthen, Sathana;
    • Zhi Ling Teo;
    • Caramia, Franco;
    • Savas, Peter;
    • Mintoff, Christopher P.;
    • Virassamy, Balaji;
    • Henderson, Melissa A.;
    • Luen, Stephen J.;
    • Mansour, Mariam;
    • Kershaw, Michael H.;
    • Trapani, Joseph A.;
    • Neeson, Paul J.;
    • Salgado, Roberto;
    • McArthur, Grant A.;
    • Balko, Justin M.;
    • Beavis, Paul A.;
    • Darcy, Phillip K.;
    • Loi, Sherene
    Publication type:
    Article
    40

    TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251327992
    By:
    • Schmid, Peter;
    • Oliveira, Mafalda;
    • O'Shaughnessy, Joyce;
    • Cristofanilli, Massimo;
    • Graff, Stephanie L.;
    • Im, Seock-Ah;
    • Loi, Sherene;
    • Saji, Shigehira;
    • Wang, Shusen;
    • Cescon, David W.;
    • Hovey, Tina;
    • Nawrot, Agata;
    • Tse, Karson;
    • Vukovic, Petra;
    • Curigliano, Giuseppe
    Publication type:
    Article
    41

    Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231178125
    By:
    • Slamon, Dennis J.;
    • Fasching, Peter A.;
    • Hurvitz, Sara;
    • Chia, Stephen;
    • Crown, John;
    • Martín, Miguel;
    • Barrios, Carlos H.;
    • Bardia, Aditya;
    • Im, Seock-Ah;
    • Yardley, Denise A.;
    • Untch, Michael;
    • Huang, Chiun-Sheng;
    • Stroyakovskiy, Daniil;
    • Xu, Binghe;
    • Moroose, Rebecca L.;
    • Loi, Sherene;
    • Visco, Frances;
    • Bee-Munteanu, Valerie;
    • Afenjar, Karen;
    • Fresco, Rodrigo
    Publication type:
    Article
    42
    43
    44
    45
    46

    Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.

    Published in:
    Clinical Chemistry, 2019, v. 65, n. 11, p. 1405, doi. 10.1373/clinchem.2019.305805
    By:
    • O’Leary, Ben;
    • Hrebien, Sarah;
    • Beaney, Matthew;
    • Fribbens, Charlotte;
    • Garcia-Murillas, Isaac;
    • Jiang, John;
    • Li, Yuan;
    • Bartlett, Cynthia Huang;
    • Andre´, Fabrice;
    • Loibl, Sibylle;
    • Loi, Sherene;
    • Cristofanilli, Massimo;
    • Turner, Nicholas C.
    Publication type:
    Article
    47
    48

    Deciphering clonality in aneuploid tumors using SNP array and sequencing data.

    Published in:
    Genome Biology, 2014, v. 15, n. 9, p. 1, doi. 10.1186/s13059-014-0470-7
    By:
    • Lönnstedt, Ingrid M.;
    • Caramia, Franco;
    • Jason Li;
    • Fumagalli, Debora;
    • Salgado, Roberto;
    • Rowan, Andrew;
    • Salm, Max;
    • Kanu, Nnennaya;
    • Savas, Peter;
    • Horswell, Stuart;
    • Gade, Stephan;
    • Loibl, Sibylle;
    • Neven, Patrick;
    • Sotiriou, Christos;
    • Swanton, Charles;
    • Sherene Loi;
    • Speed, Terence P.
    Publication type:
    Article
    49
    50